RU2019119405A3 - - Google Patents

Download PDF

Info

Publication number
RU2019119405A3
RU2019119405A3 RU2019119405A RU2019119405A RU2019119405A3 RU 2019119405 A3 RU2019119405 A3 RU 2019119405A3 RU 2019119405 A RU2019119405 A RU 2019119405A RU 2019119405 A RU2019119405 A RU 2019119405A RU 2019119405 A3 RU2019119405 A3 RU 2019119405A3
Authority
RU
Russia
Application number
RU2019119405A
Other languages
Russian (ru)
Other versions
RU2019119405A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2019119405A publication Critical patent/RU2019119405A/ru
Publication of RU2019119405A3 publication Critical patent/RU2019119405A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
RU2019119405A 2016-11-23 2017-11-21 Лиофилизированные фармацевтические композиции далбаванцина RU2019119405A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201621039995 2016-11-23
IN201621039995 2016-11-23
PCT/IN2017/050546 WO2018096556A1 (en) 2016-11-23 2017-11-21 Lyophilized pharmaceutical compositions of dalbavancin

Publications (2)

Publication Number Publication Date
RU2019119405A RU2019119405A (ru) 2020-12-25
RU2019119405A3 true RU2019119405A3 (he) 2020-12-30

Family

ID=62194924

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019119405A RU2019119405A (ru) 2016-11-23 2017-11-21 Лиофилизированные фармацевтические композиции далбаванцина

Country Status (3)

Country Link
EP (1) EP3544616A4 (he)
RU (1) RU2019119405A (he)
WO (1) WO2018096556A1 (he)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023211501A1 (en) * 2022-04-26 2023-11-02 Hikma Pharmaceuticals Usa Inc. Stable, ready-to-administer aqueous formulations of dalbavancin
WO2024079223A1 (en) * 2022-10-12 2024-04-18 Xellia Pharmaceuticals Aps Liquid dalbavancin composition
WO2024079224A1 (en) * 2022-10-12 2024-04-18 Xellia Pharmaceuticals Aps Liquid dalbavancin composition
EP4431084A1 (en) * 2023-03-16 2024-09-18 Adalvo Limited Formulation of dalbavancin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
EP3581186A1 (en) * 2012-11-29 2019-12-18 Insmed Incorporated Stabilized vancomycin formulations
CA2964524A1 (en) * 2014-11-06 2016-05-12 Xellia Pharmaceuticals Aps Glycopeptide compositions

Also Published As

Publication number Publication date
RU2019119405A (ru) 2020-12-25
EP3544616A1 (en) 2019-10-02
EP3544616A4 (en) 2020-12-09
WO2018096556A1 (en) 2018-05-31

Similar Documents

Publication Publication Date Title
CH715083A2 (he)
BR112018068177A2 (he)
BR112019001429A2 (he)
BR112019009262A2 (he)
CN303548457S (he)
CN303546123S (he)
CN303536548S (he)
CN303536549S (he)
CN303537327S (he)
CN303537475S (he)
CN303537535S (he)
CN303537757S (he)
CN303538213S (he)
CN303538997S (he)
CN303539227S (he)
CN303539291S (he)
CN303539683S (he)
CN303541210S (he)
CN303541351S (he)
CN303541522S (he)
CN303541670S (he)
CN303542457S (he)
CN303542461S (he)
CN303542471S (he)
CN303543097S (he)

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20220207